+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 7 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.

All AgesAll Genders
305 locations
C

Actively Recruiting

Researchers are evaluating two surgical methods for repairing primary inguinal hernias the Desarda technique, which does not use mesh, and the Lichtenstein technique, which involves mesh. The study aims to determine which method results in fewer postoperative complications. Patients with unilateral inguinal hernia and complications from surgical procedures or medical care are included in this interventional trial. Participants are randomly assigned to one of two groups one receiving the Desarda surgical method and the other receiving the Lichtenstein method. Both are surgical procedures performed via an anterior approach, either as outpatient surgery or elective admission. The trial uses a parallel study design with triple masking to compare outcomes between these techniques. During the study, participants undergo surgery and are monitored for complications for at least three months after the procedure. Researchers will assess the rate of post-surgery complications as the primary outcome measure. The study is sponsored by Consorci Sanitari de lAlt Peneds i Garraf and aims to complete by December 2031, with primary data collection ending in December 2028.

Age: 18Years +All GendersPhase Not Applicable
1 location
H

Actively Recruiting

The HIP ATTACK-2 trial is an international, multicenter randomized controlled study investigating whether accelerated surgery for patients with hip fractures and acute myocardial injury reduces death within 90 days compared to standard care. The trial also evaluates secondary outcomes such as the ability to walk independently, time to first mobilization, major complications including heart and stroke events, delirium, length of hospital stay, pain, and quality of life. Participants are assigned to either accelerated medical clearance with surgery within 6 hours of meeting eligibility or to standard surgical care following hospital guidelines. The accelerated group receives rapid preparation aimed at timely hip fracture repair, while the standard care group undergoes usual surgical timing and procedures. Both groups receive hip fracture repair and surgical care according to treating institution protocols. During the study, participants are monitored for mortality and other health outcomes up to 90 days after randomization. Assessments include walking ability, major cardiovascular events, delirium, pain levels, hospital discharge timing, and overall quality of life. Safety and recovery progress are closely followed to understand the impact of surgery timing on these important measures.

Age: 45Years +All GendersPhase Not Applicable
77 locations
E

Actively Recruiting

Researchers are evaluating the usefulness of the NECPAL scale to identify patients admitted to the Intensive Care Unit ICU who may have a higher risk of dying within 90 days of ICU admission. This observational study focuses on older adults aged 75 years or older in the ICU setting. The study is sponsored by Consorci Sanitari de lAlt Peneds i Garraf. Participants are observed based on their NECPAL scale results, with one group having a positive NECPAL result. The study does not involve any treatment or intervention but collects data to assess the association between a positive NECPAL score and mortality risk. During the study, participants health status and outcomes are monitored for up to 90 days from ICU admission. Researchers measure mortality within this timeframe to evaluate the NECPAL scales predictive value. The study involves informed consent from participants or their legal representatives and excludes those who die within the first 24 hours of ICU admission.

Age: 75Years +All Genders
1 location
R

Actively Recruiting

Researchers are evaluating the safety of remote consultations, including video and telephone appointments, compared to traditional face-to-face consultations for patients in a hospital setting. This randomized controlled trial aims to assess whether remote follow-up is as safe as in-person visits by measuring complications related to the patients underlying diseases over a 12-month period. The study includes a total of 2136 patients randomly assigned to one of three groups face-to-face consultation, video consultation, or telephone consultation. Participants will receive follow-up care through either in-person visits or remote consultations delivered by phone or video. Physicians will schedule at least three visits per participant a baseline screening visit, several intermediate visits based on medical need, and a final visit around 12 months after enrollment or earlier if the patient is discharged or discontinues early. Remote consultation patients will be reminded of appointments via text or call. Telephone consultations involve the doctor calling the patient or their family at the scheduled time, while video consultations use a secure application with a virtual waiting room. During the study, participants will be monitored for complications, serious adverse events, avoidable hospitalizations, and unscheduled medical contacts. Researchers will also evaluate healthcare costs, usability of the video system, and satisfaction of both patients and health professionals with the care process. All interactions, including phone calls for control participants, will be recorded. The total participation duration is about 12 months, with physicians able to schedule or cancel appointments as needed throughout this period.

All AgesAll GendersPhase Not Applicable
3 locations
D

Actively Recruiting

This research aims to develop a predictive model to identify elderly patients aged 75 and older who have the highest likelihood of mortality when admitted to an intensive care unit ICU with critical illness. The study focuses on understanding factors that affect survival after ICU admission for this population. The study is observational and sponsored by Consorci Sanitari de lAlt Peneds i Garraf. Participants will undergo laboratory biomarker analysis, where results will be examined as predictors for mortality. The study involves observing patients admitted to the ICU from the Emergency Department without administering any additional treatments or interventions. The main goal is to analyze these laboratory results to build a model that can predict mortality risk at 90 days after ICU admission. During the study, participants clinical data and laboratory biomarkers will be collected and analyzed. Researchers will track mortality at 90 days post-admission as the primary outcome. Participants must provide informed consent or have a legal representative consent on their behalf. The study will continue through December 2028, with no specific visits or procedures beyond routine ICU care and data collection.

Age: 75Years +All Genders
14 locations
S

Actively Recruiting

Researchers are studying how often amyloidosis occurs in patients undergoing trauma surgery. This observational study aims to identify the presence of amyloidosis using a red flags tool among patients who meet specific risk criteria such as older age or certain heart, nerve, kidney, or liver conditions. The study is sponsored by Consorci Sanitari de lAlt Peneds i Garraf. Participants are patients scheduled for trauma surgery who have at least one risk factor for amyloidosis, including being over 65 years old or having a history of certain cardiac, neurological, or organ diseases. The study involves observing these patients during their routine trauma surgery without additional treatments assigned by the study. During the study, participants will undergo evaluations to detect amyloidosis within one month after surgery. Researchers will review medical history, tests such as echocardiography and blood markers, and other clinical data. Participation requires signing informed consent and the ability to cooperate with evaluations. The study excludes those already diagnosed with amyloidosis.

All AgesAll Genders
1 location